MESSA, MARIA CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 26.848
AS - Asia 10.776
EU - Europa 10.347
SA - Sud America 1.498
Continente sconosciuto - Info sul continente non disponibili 549
AF - Africa 238
OC - Oceania 22
Totale 50.278
Nazione #
US - Stati Uniti d'America 25.214
SG - Singapore 3.953
IT - Italia 2.764
CN - Cina 2.520
CA - Canada 1.452
HK - Hong Kong 1.394
SE - Svezia 1.393
RU - Federazione Russa 1.308
DE - Germania 1.241
BR - Brasile 1.128
VN - Vietnam 1.109
UA - Ucraina 947
IE - Irlanda 857
GB - Regno Unito 523
BD - Bangladesh 402
FR - Francia 385
IN - India 307
FI - Finlandia 266
KR - Corea 180
TR - Turchia 162
AR - Argentina 128
IQ - Iraq 117
JP - Giappone 116
PL - Polonia 89
NL - Olanda 86
DK - Danimarca 79
ES - Italia 79
AT - Austria 77
MX - Messico 74
ZA - Sudafrica 74
ID - Indonesia 64
PK - Pakistan 59
SA - Arabia Saudita 56
EC - Ecuador 55
CO - Colombia 50
BG - Bulgaria 48
BE - Belgio 43
PH - Filippine 40
VE - Venezuela 40
MY - Malesia 36
UZ - Uzbekistan 32
CH - Svizzera 30
MA - Marocco 30
CL - Cile 26
KE - Kenya 26
TH - Thailandia 24
AE - Emirati Arabi Uniti 23
PY - Paraguay 23
TN - Tunisia 23
ET - Etiopia 22
UY - Uruguay 20
HN - Honduras 19
IR - Iran 19
PE - Perù 19
CZ - Repubblica Ceca 18
AU - Australia 17
CR - Costa Rica 17
EU - Europa 17
MV - Maldive 16
JM - Giamaica 15
JO - Giordania 15
NI - Nicaragua 15
PT - Portogallo 15
EG - Egitto 14
IL - Israele 14
RO - Romania 14
GR - Grecia 13
LT - Lituania 13
TW - Taiwan 13
KG - Kirghizistan 12
AL - Albania 11
AZ - Azerbaigian 11
NP - Nepal 11
PS - Palestinian Territory 11
LB - Libano 10
DZ - Algeria 9
HU - Ungheria 9
OM - Oman 9
KZ - Kazakistan 8
GE - Georgia 7
PA - Panama 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
EE - Estonia 6
GT - Guatemala 6
LK - Sri Lanka 6
PR - Porto Rico 6
MK - Macedonia 5
BH - Bahrain 4
NO - Norvegia 4
RS - Serbia 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BS - Bahamas 3
CI - Costa d'Avorio 3
LY - Libia 3
MM - Myanmar 3
Totale 49.680
Città #
Ann Arbor 2.952
Ashburn 2.429
Singapore 2.190
Woodbridge 2.019
Fairfield 1.742
Houston 1.601
Hong Kong 1.360
San Jose 1.111
Chandler 1.059
Toronto 1.048
Jacksonville 1.041
Milan 996
Dublin 816
Wilmington 738
Dearborn 708
Frankfurt am Main 656
Seattle 637
Cambridge 579
Santa Clara 567
New York 566
Council Bluffs 428
Princeton 382
Chicago 347
Beijing 327
Los Angeles 324
The Dalles 292
Hefei 288
Ho Chi Minh City 284
Dallas 268
Hanoi 230
Nanjing 228
Rome 200
Lawrence 183
Lauterbourg 174
Shanghai 173
Lachine 171
Seoul 169
Altamura 166
Buffalo 134
Boardman 127
Moscow 121
San Diego 110
São Paulo 102
Dong Ket 90
Guangzhou 83
Shenyang 82
Columbus 73
Helsinki 73
Nanchang 72
Tokyo 69
Lissone 68
Ottawa 68
Hebei 62
Vienna 62
Falls Church 60
Brooklyn 57
Munich 57
Changsha 55
Phoenix 55
Montreal 54
Atlanta 53
Andover 50
Orem 50
Da Nang 49
Jiaxing 48
Jinan 46
London 46
Huizen 45
Tianjin 45
Warsaw 44
Figino 42
Mountain View 42
Baghdad 41
Denver 41
Plovdiv 41
Turin 40
Philadelphia 37
Brussels 36
Haiphong 36
Chennai 35
Dhaka 35
Norwalk 35
Salt Lake City 32
Jakarta 30
Rio de Janeiro 30
Boston 29
Johannesburg 29
Kraków 29
Nuremberg 29
Tashkent 29
Washington 29
Fremont 28
Stockholm 28
Zhengzhou 28
Amsterdam 27
Lahore 27
Naples 27
Spoltore 26
Jeddah 25
Ningbo 25
Totale 32.627
Nome #
Use of legal and illegal substances in Malé (Republic of Maldives) assessed by wastewater analysis 675
Methotrexate inhibits SARS-CoV-2 virus replication "in vitro" 598
Sustainable mobility management at the University of Milan-Bicocca 561
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 502
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 477
BASE: A sustainable path for the University of Milano-Bicocca 475
Radio guided radical prostatectomy: Evaluation of feasibility, safety and clinical outcomes 473
Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006-2007 472
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 470
Machine learning applied on chest x-ray can aid in the diagnosis of COVID-19: a first experience from Lombardy, Italy 449
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 449
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer 429
From cancer metabolism to new biomarkers and drug targets 416
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 412
Artificial Intelligence Applied to Chest X-ray for Differential Diagnosis of COVID-19 Pneumonia 412
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients 403
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 386
Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results 379
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT 371
Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury 369
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling 364
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 358
Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer 352
A systems biology road map for the discovery of drugs targeting cancer cell metabolism 349
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 348
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 341
11C-Choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 339
Universities as Local development Agencies in the Ambit of the Internationlization of Higher Education 339
A Low-Dose CT-Based Radiomic Model to Improve Characterization and Screening Recall Intervals of Indeterminate Prevalent Pulmonary Nodules 339
Evaluation of erlotinib treatment response in non-small cell lung cancer using metabolic and anatomic criteria 338
PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy 336
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 336
Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: Our experience and literature review 331
Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDGPET in Treatment Planning 331
Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer 329
Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment 328
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: An initial experience 327
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 325
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 324
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 320
Choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen 315
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 315
High-Intensity Focused Ultrasound– and Radiation Therapy–Induced Immuno-Modulation: Comparison and Potential Opportunities 313
Basal ganglia and language: Phonology modulates dopaminergic release 312
Sarcoidosis mimicking metastatic gynaecological malignancies: a diagnostic and therapeutic challenge? 308
Patients with known or suspected lung cancer: evaluation of clinical management changes due to f-fluorodeoxyglucose positron emission tomography (f-fdg pet) study 308
Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study 307
Incidental finding of parathyroid adenoma with 11C-choline PET/CT 302
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 296
Lung Regional Metabolic Activity and Gas Volume Changes Induced by Tidal Ventilation in Patients with Acute Lung Injury 294
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 288
Corpus callosum agenesis and epilepsy: PET findings 287
[ 11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: Comparison with bone scintigraphy 286
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 283
Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: A cost-effectiveness analysis 282
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 282
Gli obiettivi, le strategie e le azioni dell’università di Milano-Bicocca 282
Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy 280
High-grade endometrial cancer: value of [18F]FDG PET/CT in preoperative staging 279
Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky-Bielschowsky disease): a case report 277
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 276
Performance measurements for the PET/CT Discovery-600 using NEMA NU 2-2007 standards 275
Quantification of Dynamic [18F]FDG Pet Studies in Acute Lung Injury 275
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence 272
Progressive dysphasic dementia with bucco-facial apraxia: A case report 272
SPET imaging of cerebral perfusion in patients with non‐refractory temporal lobe epilepsy 271
Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: Correlation with bone histomorphometry 270
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 270
Can magnetic resonance image-guided focused ultrasound surgery replace local oncology treatments? A review 269
Whole-body scintigraphy with 99Tcm-mibi, 18f-fdg and 131I in patients with metastatic thyroid carcinoma 268
Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [(18F)]fluorodeoxyglucose PET and CT comparison 266
Computed Tomography Correlates of Chronic Unilateral Neglect 266
Positron emission tomograhy for the assessment of myocardial viability: A sinopsys of methods and indications 265
Hemimegalencephaly: evaluation with positron emission tomography 263
Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer 261
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 260
Acute effect of 3-(4-acetamido)-butyrril-lorazepam (dds2700) on brain function assessed by pet at rest and during attentive tasks 260
[(11)C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy 258
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases 258
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study 257
Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method 257
Imaging of lung inflammation during severe influenza A: H1N1 255
[(11)C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging 254
The role of positron emission tomography in oncology and other whole-body applications 254
Focal bone lesions in hiv-positive patient treated with tenofovir 252
(18)-F-fluorodeoxyglucose positron emission tomography/computed tomography study in acute lung injury/acute respiratory distress syndrome 251
Portrait of inflammatory response to ionizing radiation treatment 251
Increased 5-Hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: A positron emission tomography scan study 250
Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology 249
Automatic registration of PET and CT studies for clinical use in thoracic and abdominal conformal radiotherapy 248
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 248
Multifocal, persistent cardiac uptake of [18-F]-Fluoro-Deoxy-Glucose detected by positron emission tomography in patients with acute myocardial infarction 247
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 247
Value of integrated PET/CT for lesion localisation in cancer patients: A comparative study 245
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 245
A GEANT4 web-based application to support Intra-Operative Electron Radiotherapy using the European grid infrastructure 245
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 244
Caveolin-1, breast cancer and ionizing radiation 244
PET-CT for treatment planning in prostate cancer 243
Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers 243
Totale 32.132
Categoria #
all - tutte 156.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.954 0 0 0 296 133 159 153 145 144 180 311 433
2022/20234.150 514 1.172 324 442 323 636 41 220 274 34 115 55
2023/20242.455 101 88 111 93 349 680 506 83 173 26 15 230
2024/20255.856 376 786 241 254 471 295 258 303 546 765 550 1.011
2025/202615.260 1.386 924 1.052 1.386 1.613 855 1.972 815 1.222 1.281 1.520 1.234
2026/20272.758 369 682 1.525 182 0 0 0 0 0 0 0 0
Totale 50.278